RSCM
KRTX
Rock Springs Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-515,024
| Closed | -$163M | – | 116 |
|
2023
Q4 | $163M | Buy |
515,024
+9,591
| +2% | +$3.04M | 4.01% | 3 |
|
2023
Q3 | $85.5M | Buy |
505,433
+11,906
| +2% | +$2.01M | 2.29% | 11 |
|
2023
Q2 | $107M | Hold |
493,527
| – | – | 2.55% | 11 |
|
2023
Q1 | $89.6M | Buy |
493,527
+79,765
| +19% | +$14.5M | 2.14% | 13 |
|
2022
Q4 | $81.3M | Hold |
413,762
| – | – | 1.96% | 16 |
|
2022
Q3 | $93.1M | Sell |
413,762
-28,131
| -6% | -$6.33M | 2.4% | 10 |
|
2022
Q2 | $55.9M | Buy |
441,893
+9,350
| +2% | +$1.18M | 1.63% | 19 |
|
2022
Q1 | $54.8M | Buy |
432,543
+5,700
| +1% | +$723K | 1.38% | 25 |
|
2021
Q4 | $55.9M | Buy |
426,843
+34,926
| +9% | +$4.58M | 1.29% | 26 |
|
2021
Q3 | $47.9M | Buy |
391,917
+5,299
| +1% | +$648K | 1.01% | 32 |
|
2021
Q2 | $44.1M | Buy |
386,618
+17,854
| +5% | +$2.04M | 0.87% | 35 |
|
2021
Q1 | $44.3M | Buy |
368,764
+124,814
| +51% | +$15M | 0.97% | 33 |
|
2020
Q4 | $24.8M | Sell |
243,950
-156
| -0.1% | -$15.8K | 0.53% | 65 |
|
2020
Q3 | $18.9M | Buy |
244,106
+40,794
| +20% | +$3.15M | 0.48% | 69 |
|
2020
Q2 | $22.7M | Buy |
203,312
+23,312
| +13% | +$2.6M | 0.62% | 56 |
|
2020
Q1 | $13M | Hold |
180,000
| – | – | 0.54% | 62 |
|
2019
Q4 | $13.6M | Sell |
180,000
-180,400
| -50% | -$13.6M | 0.43% | 77 |
|
2019
Q3 | $5.88M | Sell |
360,400
-53,100
| -13% | -$867K | 0.23% | 97 |
|
2019
Q2 | $8.28M | Buy |
+413,500
| New | +$8.28M | 0.3% | 86 |
|